WO2000009639A3 - Fatty ester combinations - Google Patents

Fatty ester combinations Download PDF

Info

Publication number
WO2000009639A3
WO2000009639A3 PCT/US1999/017935 US9917935W WO0009639A3 WO 2000009639 A3 WO2000009639 A3 WO 2000009639A3 US 9917935 W US9917935 W US 9917935W WO 0009639 A3 WO0009639 A3 WO 0009639A3
Authority
WO
WIPO (PCT)
Prior art keywords
fatty ester
ester combinations
compositions containing
combinations
thermoforming
Prior art date
Application number
PCT/US1999/017935
Other languages
French (fr)
Other versions
WO2000009639A2 (en
Inventor
Nils Ahlgren
Joseph Cascone
Joan Fitzpatrick
Steven E Frisbee
John Getz
Mark R Herman
Bernard M Kiernan
Barbara Montwill
Edward P O'donnell
Desiree Pereira
Pradeepkumar P Sanghvi
Original Assignee
Fuisz Technologies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fuisz Technologies Ltd filed Critical Fuisz Technologies Ltd
Priority to AU54702/99A priority Critical patent/AU5470299A/en
Publication of WO2000009639A2 publication Critical patent/WO2000009639A2/en
Publication of WO2000009639A3 publication Critical patent/WO2000009639A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats

Abstract

The thermoforming of compositions containing active agents is carried out by processing compositions containing certain fatty esters in combination.
PCT/US1999/017935 1998-08-12 1999-08-10 Fatty ester combinations WO2000009639A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU54702/99A AU5470299A (en) 1998-08-12 1999-08-10 Fatty ester combinations

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/132,922 1998-08-12
US09/132,922 US6117452A (en) 1998-08-12 1998-08-12 Fatty ester combinations

Publications (2)

Publication Number Publication Date
WO2000009639A2 WO2000009639A2 (en) 2000-02-24
WO2000009639A3 true WO2000009639A3 (en) 2002-09-19

Family

ID=22456183

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/017935 WO2000009639A2 (en) 1998-08-12 1999-08-10 Fatty ester combinations

Country Status (3)

Country Link
US (1) US6117452A (en)
AU (1) AU5470299A (en)
WO (1) WO2000009639A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8834925B2 (en) 2006-08-25 2014-09-16 Purdue Pharma L.P. Tamper resistant dosage forms

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2348452A1 (en) * 1998-10-27 2000-05-04 Biovail Technologies Ltd. Microparticles containing peg and/or peg glyceryl esters
US7815937B2 (en) * 1998-10-27 2010-10-19 Biovail Laboratories International Srl Quick dissolve compositions and tablets based thereon
KR100463496B1 (en) * 1999-09-30 2005-01-06 펜웨스트 파머슈티칼즈 컴파니 Sustained release matrix systems for highly soluble drugs
AU2001235971A1 (en) * 2000-12-07 2002-06-18 College Of Pharmacy A novel anti-fertility agent
US7273623B2 (en) 2001-10-12 2007-09-25 Kiel Laboratories, Inc. Process for preparing tannate tablet, capsule or other solid dosage forms
US6869618B2 (en) * 2001-04-10 2005-03-22 Kiel Laboratories, Inc. Process for preparing tannate liquid and semi-solid dosage forms
US20030060422A1 (en) 2001-08-31 2003-03-27 Balaji Venkataraman Tannate compositions and methods of treatment
US6509492B1 (en) 2001-08-31 2003-01-21 First Horizon Pharmaceutical Corporation Tannate compositions and methods of treatment
US6723348B2 (en) * 2001-11-16 2004-04-20 Ethypharm Orodispersible tablets containing fexofenadine
US8128957B1 (en) 2002-02-21 2012-03-06 Valeant International (Barbados) Srl Modified release compositions of at least one form of tramadol
US20050182056A9 (en) * 2002-02-21 2005-08-18 Seth Pawan Modified release formulations of at least one form of tramadol
WO2003086346A1 (en) * 2002-04-09 2003-10-23 Kiel Laboratories, Inc. Diphenhydramine tannate compositions and methods of use
US7148376B2 (en) * 2002-07-18 2006-12-12 Teva Pharmaceutical Industries Ltd. Polymorphic forms of nateglinide
JP2006518380A (en) * 2003-01-31 2006-08-10 スミスクライン・ビーチャム・コーポレイション Solid dispersion composition
MXPA05008838A (en) * 2003-02-19 2006-02-17 Biovail Lab Int Srl Rapid absorption selective 5-ht agonist formulations.
WO2004093866A1 (en) * 2003-03-25 2004-11-04 Kiel Laboratories, Inc. Process for preparing phenolic acid salts of gabapentin
WO2004093827A2 (en) * 2003-03-25 2004-11-04 Kiel Laboratories, Inc. Phenolic acid salts of gabapentin in solid dosage forms and methods of use
EP1628656B1 (en) * 2003-03-25 2008-10-15 Kiel Laboratories, Inc. Gabapentin tannate in liquid and/or semi-solid dosage forms
WO2004108092A2 (en) * 2003-06-05 2004-12-16 P3 Laboratories, Inc. Tannate compositions and methods of use
US20050238718A1 (en) 2003-08-08 2005-10-27 Werner Oberegger Modified-release tablet of bupropion hydrochloride
AU2004294813A1 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Spray-congeal process using an extruder for preparing multiparticulate azithromycin compositions containing preferably a poloxamer and a glyceride
CA2547774A1 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Method for making pharmaceutical multiparticulates
JP2007513147A (en) * 2003-12-04 2007-05-24 ファイザー・プロダクツ・インク Spray congealing process for producing a multiparticulate crystalline pharmaceutical composition, preferably containing poloxamer and glyceride, using an extruder
US6984403B2 (en) * 2003-12-04 2006-01-10 Pfizer Inc. Azithromycin dosage forms with reduced side effects
WO2005053652A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
EP1694304A2 (en) * 2003-12-04 2006-08-30 Pfizer Products Inc. Azithromycin multiparticulate dosage forms by liquid-based processes
WO2005053639A2 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Controlled release multiparticulates formed with dissolution enhancers
CA2547597A1 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate compositions with improved stability
GB0400452D0 (en) * 2004-01-09 2004-02-11 Norton Healthcare Ltd A pharmaceutical composition
CA2561855A1 (en) * 2004-04-12 2005-10-20 Pfizer Products Inc. Taste-masked drugs in rupturing multiparticulates
JP5443768B2 (en) 2006-03-16 2014-03-19 ユーロセルティック ソシエテ アノニム Pharmaceutical spheres
WO2008065504A1 (en) * 2006-11-30 2008-06-05 Pfizer Products Inc. Multiparticulates of spray-coated drug and polymer on a meltable core
US11116728B2 (en) 2006-11-30 2021-09-14 Bend Research, Inc. Multiparticulates of spray-coated drug and polymer on a meltable core
CN104640571A (en) 2012-09-18 2015-05-20 麦克内尔-Ppc股份有限公司 Sustained release oral dosage forms comprising low melting propionic acid derivative particles
EP2897584A1 (en) 2012-09-18 2015-07-29 McNeil-PPC, Inc. Low melting propionic acid derivative particles for use in oral dosage forms

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0709086A2 (en) * 1994-10-28 1996-05-01 Fuisz Technologies Ltd. Discrete particles and method of making same
WO1999008658A1 (en) * 1997-08-20 1999-02-25 Fuisz Technologies Ltd. Fast-dissolving comestible units formed under high-speed/high-pressure conditions
WO1999013864A2 (en) * 1997-09-19 1999-03-25 Shire Laboratories, Inc. Solid solution beadlet

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4132753A (en) * 1965-02-12 1979-01-02 American Cyanamid Company Process for preparing oral sustained release granules
DE3421468A1 (en) * 1984-06-08 1985-12-19 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim LIPID NANOPELLETS AS A CARRIER SYSTEM FOR MEDICINAL PRODUCTS FOR PERORAL USE
US4837381A (en) * 1986-08-11 1989-06-06 American Cyanamid Company Compositions for parenteral administration and their use
DE3709861A1 (en) * 1987-03-25 1988-10-06 Henkel Kgaa EMULSIFYING SUPPOSITORIES AND MEASURES PRODUCED FROM THEM
US5011532A (en) * 1988-03-18 1991-04-30 Fuisz Pharmaceutical Ltd. Dispersed systems and method of manufacture
US4970081A (en) * 1989-01-03 1990-11-13 Sterling Drug Inc. Controlled-release, low-dose aspirin formulation and method of treating vascular occlusive disease therewith
US5169645A (en) * 1989-10-31 1992-12-08 Duquesne University Of The Holy Ghost Directly compressible granules having improved flow properties
US5213810A (en) * 1990-03-30 1993-05-25 American Cyanamid Company Stable compositions for parenteral administration and method of making same
US5234695A (en) * 1990-07-24 1993-08-10 Eastman Kodak Company Water dispersible vitamin E composition
US5571533A (en) * 1992-02-07 1996-11-05 Recordati, S.A., Chemical And Pharmaceutical Company Controlled-release mucoadhesive pharmaceutical composition for the oral administration of furosemide
US5895664A (en) * 1993-09-10 1999-04-20 Fuisz Technologies Ltd. Process for forming quickly dispersing comestible unit and product therefrom
IL110752A (en) * 1993-09-13 2000-07-26 Abbott Lab Liquid semi-solid or solid pharmaceutical composition for an HIV protease inhibitor
US5433951A (en) * 1993-10-13 1995-07-18 Bristol-Myers Squibb Company Sustained release formulation containing captopril and method
US5567439A (en) * 1994-06-14 1996-10-22 Fuisz Technologies Ltd. Delivery of controlled-release systems(s)
US5883103A (en) * 1995-06-07 1999-03-16 Shire Laboratories Inc. Oral acyclovir delivery
US5851555A (en) * 1997-08-15 1998-12-22 Fuisz Technologies Ltd. Controlled release dosage forms containing water soluble drugs
US5840334A (en) * 1997-08-20 1998-11-24 Fuisz Technologies Ltd. Self-binding shearform compositions

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0709086A2 (en) * 1994-10-28 1996-05-01 Fuisz Technologies Ltd. Discrete particles and method of making same
WO1999008658A1 (en) * 1997-08-20 1999-02-25 Fuisz Technologies Ltd. Fast-dissolving comestible units formed under high-speed/high-pressure conditions
WO1999013864A2 (en) * 1997-09-19 1999-03-25 Shire Laboratories, Inc. Solid solution beadlet

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8834925B2 (en) 2006-08-25 2014-09-16 Purdue Pharma L.P. Tamper resistant dosage forms
US8846086B2 (en) 2006-08-25 2014-09-30 Purdue Pharma L.P. Tamper resistant dosage forms
US8894988B2 (en) 2006-08-25 2014-11-25 Purdue Pharma L.P. Tamper resistant dosage forms
US8894987B2 (en) 2006-08-25 2014-11-25 William H. McKenna Tamper resistant dosage forms
US8911719B2 (en) 2006-08-25 2014-12-16 Purdue Pharma Lp Tamper resistant dosage forms
US9084816B2 (en) 2006-08-25 2015-07-21 Purdue Pharma L.P. Tamper resistant dosage forms
US9095614B2 (en) 2006-08-25 2015-08-04 Purdue Pharma L.P. Tamper resistant dosage forms
US9095615B2 (en) 2006-08-25 2015-08-04 Purdue Pharma L.P. Tamper resistant dosage forms
US9101661B2 (en) 2006-08-25 2015-08-11 Purdue Pharma L.P. Tamper resistant dosage forms

Also Published As

Publication number Publication date
AU5470299A (en) 2000-03-06
WO2000009639A2 (en) 2000-02-24
US6117452A (en) 2000-09-12

Similar Documents

Publication Publication Date Title
WO2000009639A3 (en) Fatty ester combinations
AU5507996A (en) Fatty acid esters as bioactive compounds
AU2590897A (en) Betaine ester compounds of active alcohols
AU5678494A (en) Low sudsing polyhydroxy fatty acid amide detergents
AU671329B2 (en) Formulations containing unsaturated fatty acids
WO2002094210A3 (en) Cosmetic agents
CA2174658A1 (en) Novel Composition
CA2225797A1 (en) Active principle carriers containing non-ionic surfactants, and uses thereof, particularly in food, cosmetics and pharmaceuticals
AU2001238315A1 (en) Pet foods using algal or fungal waste containing fatty acids
AU7442398A (en) Glucosamine fatty acid compositions and their use
AU4699996A (en) Epoxy-cyanate ester compositions
WO2000071183A8 (en) Antimicrobial articles
AU2013097A (en) Cosmetic composition with long chain unsaturated retinol fatty acid esters
CA2202338A1 (en) Skin care compositions containing fatty acid amides, azoles and retinol or retinyl ester
AU7300294A (en) Sulfonation of fatty acid esters
AU5174596A (en) Fatty acid based compositions and methods for the control of plant infections and pests
AU3367899A (en) Modification of fatty acid composition in plants by expression of an (aspergillus nidulans) delta-9 coa desaturase
ZA986532B (en) Benefit agent compositions comprising mixtures of alpha-hydroxy esters.
AU3702997A (en) Manufacture of fatty acid esters of sorbitan as surfactants
WO2000037057A3 (en) Novel formulations comprising lipid-regulating agents
AU6968798A (en) Phorbol esters as anti-neoplastic agents
AU6409299A (en) Alkoxylated fatty alcohol dicarboxylic acid esters
AU5334894A (en) Compositions of fatty acid esters of hexitans
AU6948194A (en) Inhibition of expression of beta-lactamase using esters of fatty acid alcohols
AU2614200A (en) Composition for stabilizing and potentiating the action of anti-angiogenic substances by polyunsaturated fatty acids

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

122 Ep: pct application non-entry in european phase